Perspectives & Progress

T.Rx Capital Launches $77.5M Fund I to Invest in Bold Startups at the Intersection of Technology and Biology

New venture capital firm to create and invest in early-stage healthcare companies applying novel technologies to frontier biology and redefine patient care

Radiopharmaceuticals: The Next Frontier in Precision Cancer Care

Radiopharmaceuticals are emerging as the future of cancer care, combining targeted precision with powerful radiation to deliver safer, more effective treatments.

New Non-Opioid Pain Medications: Redefining Relief in the Post-Opioid Era

Biotech companies are racing to develop non-opioid pain medications as safer, effective alternatives to addictive opioids, with breakthroughs like Vertex’s FDA-approved Journavx leading a new era in pain management.

Robert Langer, co‑founder of Moderna and MIT Institute Professor

Chemical engineer and biotechnology pioneer in controlled drug delivery, mRNA therapeutics, and tissue engineering. Co-founder of Moderna and leader in biomedical innovation.

Jonathan Bush: Why Healthcare Needs More Rule Breakers

Jonathan Bush, CEO of Zus Health, shares his vision on how artificial intelligence can transform healthcare by automating administrative tasks and why disruptive innovation is crucial in the sector.

Newsweek Recognizes Recuro Health as One of the World’s Best Digital Health Companies in 2024

Digital-first healthcare provider honored by Newsweek and Statista as a top innovator in virtual primary, urgent, behavioral care, genomics, and at-home testing—solidifying its leadership in telehealth.

Ready to Transform Healthcare?

Join us in building the future of medicine through innovative technology and biology convergence